Biology

Diversification of the type IV filament superfamily into machines for adhesion, protein secretion, DNA uptake, and motility

by Rémi Denise, Sophie S. Abby, Eduardo P. C. Rocha

Processes of molecular innovation require tinkering and shifting in the function of existing genes. How this occurs in terms of molecular evolution at long evolutionary scales remains poorly understood. Here, we analyse the natural history of a vast group of membrane-associated molecular systems in Bacteria and Archaea—the type IV filament (TFF) superfamily—that diversified in systems involved in flagellar or twitching motility, adhesion, protein secretion, and DNA uptake. The phylogeny of the thousands of detected systems suggests they may have been present in the last universal common ancestor. From there, two lineages—a bacterial and an archaeal—diversified by multiple gene duplications, gene fissions and deletions, and accretion of novel components. Surprisingly, we find that the ‘tight adherence’ (Tad) systems originated from the interkingdom transfer from Archaea to Bacteria of a system resembling the ‘EppA-dependent’ (Epd) pilus and were associated with the acquisition of a secretin. The phylogeny and content of ancestral systems suggest that initial bacterial pili were engaged in cell motility and/or DNA uptake. In contrast, specialised protein secretion systems arose several times independently and much later in natural history. The functional diversification of the TFF superfamily was accompanied by genetic rearrangements with implications for genetic regulation and horizontal gene transfer: systems encoded in fewer loci were more frequently exchanged between taxa. This may have contributed to their rapid evolution and spread across Bacteria and Archaea. Hence, the evolutionary history of the superfamily reveals an impressive catalogue of molecular evolution mechanisms that resulted in remarkable functional innovation and specialisation from a relatively small set of components.

Source link




Related posts

New patent expiration for Keryx Biopharms drug AURYXIA

Newsemia

molecular biology; +250 new citations

Newsemia

Group Leader Positions (Researcher I, code 1110) – 6 year contracts

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy